好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Trends in Outcomes and Hospitalization Charges among Adult Patients with Guillain- Barrie Syndrome, Treated with Intravenous Immunoglobulin in the United States (1992-2009)
Peripheral Nerve
P01 - (-)
129
BACKGROUND: New treatments have been introduced in the last two decades for adult patients on intravenous immunoglobulin, suffering from Guillain- Barrie syndrome, which are expected to improve the associated in-hospital outcomes.
DESIGN/METHODS: We determined the rates of occurrence, in-hospital outcomes, and mean hospital charges for adult patients on intravenous immunoglobulin, hospitalized with Guillain- Barrie syndrome, from 1992 to 2009 using Nationwide Inpatient Survey (NIS).
RESULTS: The total number (N=580) of admission varied between 9 patients in 1992 to 72 patients in 2009. The proportion of males was not significantly different (P>0.7) from females during the study period. The average age (in years卤SD) was not significantly different during the study time-period and varied between 39.20卤8.01 in 1994 and 47.90卤12.3 in 1998 (P>0.75). The length of hospitalization was not significantly different during the study period (P>0.07). The maximum mean hospital stay (in days 卤standard deviation) was 14.67卤11.91 in 1992, and the minimum was 4.36卤2.9 in 1996. There was significant increase (P<0.0001) in mean hospital charges from 1992 to 2009, even after correction for inflation. The highest average hospitalization charges were $86775.34卤86642.01 in 2009, and lowest were $11946.67卤13173.4 in 1995. In-hospital mortality was not significantly different during the study period (P > 0.5).
CONCLUSIONS: Despite a continuous increase of mean hospitalization charges, there was no continuous reduction of length of hospitalization for adult patients treated with intravenous immunoglobulin, suffering from Guillain-Barrie syndrome, hospitalized from 1992 to 2009 in United States.
Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
David Miller No disclosure on file
Rania A. Elenein, MD (Jefferson Health NJ) Dr. Elenein has nothing to disclose.
Zaid Al-Qudah, MD (Associate Specialist Inc.) No disclosure on file